TY - JOUR
T1 - Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy
T2 - Association with primary tumor location
AU - Tanaka, Nobuyuki
AU - Kikuchi, Eiji
AU - Kanao, Kent
AU - Matsumoto, Kazuhiro
AU - Kobayashi, Hiroaki
AU - Ide, Hiroki
AU - Miyazaki, Yasumasa
AU - Obata, Jun
AU - Hoshino, Katsura
AU - Shirotake, Suguru
AU - Akita, Hirotaka
AU - Kosaka, Takeo
AU - Miyajima, Akira
AU - Momma, Tetsuo
AU - Nakagawa, Ken
AU - Hasegawa, Shintaro
AU - Nakajima, Yosuke
AU - Jinzaki, Masahiro
AU - Oya, Mototsugu
PY - 2014/3
Y1 - 2014/3
N2 - Purpose: To investigate the site-specific pattern of disease recurrence and/or metastasis and the associated patient outcomes after radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC). Methods: A total of 733 patients with UTUC from a retrospective multi-institutional cohort were included, with a median follow-up of 34 months. Associated patient outcomes were analyzed by multivariate analysis. To evaluate the influence of primary tumor location, we divided it into four areas: renal pelvis, and upper, middle, and lower ureter. Results: A total of 218 patients experienced disease recurrence, with the majority of relapses occurring within the first 3 years. Cumulative incidence rates of first disease recurrence at 1 and 3 years were 18.9 and 29.8 %, respectively. Of these patients, 38.5 % developed distant recurrence; 17.4 % experienced both local and distant recurrences; and 44.0 % developed isolated local recurrence. The predominant sites of distant metastasis were lung, liver, and bone. Multivariate analysis revealed that the prevalence of local recurrence and lung metastasis was significantly associated, with primary tumor location being independent of other clinicopathological variables. Lower/middle ureter tumors had a higher rate of local recurrence in the pelvic cavity, and renal pelvic tumors had a higher prevalence of distant relapse in the lungs. Similar results were obtained when rerunning the data set by excluding patients who received adjuvant chemotherapy (n = 131). Conclusions: This multi-institutional study provided a detailed picture of metastatic behavior after RNU, and primary tumor locations were associated with unique patterns of metastatic spread in UTUC patients.
AB - Purpose: To investigate the site-specific pattern of disease recurrence and/or metastasis and the associated patient outcomes after radical nephroureterectomy (RNU) in upper tract urothelial carcinoma (UTUC). Methods: A total of 733 patients with UTUC from a retrospective multi-institutional cohort were included, with a median follow-up of 34 months. Associated patient outcomes were analyzed by multivariate analysis. To evaluate the influence of primary tumor location, we divided it into four areas: renal pelvis, and upper, middle, and lower ureter. Results: A total of 218 patients experienced disease recurrence, with the majority of relapses occurring within the first 3 years. Cumulative incidence rates of first disease recurrence at 1 and 3 years were 18.9 and 29.8 %, respectively. Of these patients, 38.5 % developed distant recurrence; 17.4 % experienced both local and distant recurrences; and 44.0 % developed isolated local recurrence. The predominant sites of distant metastasis were lung, liver, and bone. Multivariate analysis revealed that the prevalence of local recurrence and lung metastasis was significantly associated, with primary tumor location being independent of other clinicopathological variables. Lower/middle ureter tumors had a higher rate of local recurrence in the pelvic cavity, and renal pelvic tumors had a higher prevalence of distant relapse in the lungs. Similar results were obtained when rerunning the data set by excluding patients who received adjuvant chemotherapy (n = 131). Conclusions: This multi-institutional study provided a detailed picture of metastatic behavior after RNU, and primary tumor locations were associated with unique patterns of metastatic spread in UTUC patients.
UR - http://www.scopus.com/inward/record.url?scp=84896735500&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84896735500&partnerID=8YFLogxK
U2 - 10.1245/s10434-013-3349-z
DO - 10.1245/s10434-013-3349-z
M3 - Article
C2 - 24217788
AN - SCOPUS:84896735500
SN - 1068-9265
VL - 21
SP - 1038
EP - 1045
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 3
ER -